Loading...
Loading...
All product recalls associated with Viatris Inc.
Total Recalls
24
Past Year
0
Class I (Serious)
1
Most Recent
Dec 2024
Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.
Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Failed Tablet/Capsule Specifications: There is a potential for the imprint, M 122, to be missing on some tablets.
CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
Failed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness.
Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.
Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.